Treatment Options for Female Urethral Problems and UTIs

Diagnosis and Classification

• The American Urological Association defines recurrent UTI as 2 or more symptomatic episodes in 6 months or 3 episodes in 1 year 3

Treatment for Acute UTI Episodes

• The European Association of Urology recommends nitrofurantoin 50-100mg four times daily for 5 days as first-line treatment for uncomplicated cystitis 2
• The European Association of Urology recommends fosfomycin trometamol 3g single dose as first-line treatment for uncomplicated cystitis 2
• The European Association of Urology recommends trimethoprim-sulfamethoxazole 160/800mg twice daily for 3 days as first-line treatment for uncomplicated cystitis, if local resistance patterns permit 2
• The European Urology guidelines suggest using a combination of amoxicillin plus an aminoglycoside, a second-generation cephalosporin plus an aminoglycoside, or an intravenous third-generation cephalosporin for complicated UTIs with systemic symptoms 4

Prevention Strategies for Recurrent UTIs

• The American College of Radiology recommends increasing fluid intake to promote more frequent urination as a non-antimicrobial approach for preventing recurrent UTIs 5
• The American College of Radiology recommends encouraging urge-initiated voiding and post-coital voiding as non-antimicrobial approaches for preventing recurrent UTIs 5
• The Journal of Urology suggests considering methenamine hippurate for women without urinary tract abnormalities as a non-antimicrobial approach for preventing recurrent UTIs 1
• The Journal of Urology recommends trying immunoactive prophylaxis, such as OM-89/Uro-Vaxom, as a non-antimicrobial approach for preventing recurrent UTIs 1
• The Journal of Urology suggests considering lactobacillus-containing probiotics, especially in combination with vaginal estrogen for postmenopausal women, as a non-antimicrobial approach for preventing recurrent UTIs 1

Special Considerations

• The Journal of the American College of Radiology recommends assessing for high postvoid residual urine volume, urinary incontinence, and cystocele in postmenopausal women 5
• The Praxis Medical Insights guidelines strongly recommend vaginal estrogen therapy as primary non-antimicrobial intervention for postmenopausal women 6
• The Praxis Medical Insights guidelines state that vaginal estrogen does not significantly increase serum estrogen levels and data do not show increased risk of breast cancer recurrence, endometrial hyperplasia, or carcinoma 6